# BeiGene, Ltd. (BGNE): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/bgne for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

BeiGene, Ltd. is a global biotechnology enterprise that operates across the entire pharmaceutical value chain, encompassing the research, development, production, and worldwide commercialization of diverse therapeutic agents. The company's commercially available product lineup includes several important medicines: BRUKINSA, an agent used for relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab, prescribed for R/R classical Hodgkin's lymphoma; REVLIMID, indicated for multiple myeloma; VIDAZA, which addresses myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid...

## Quote & Key Metrics

As of 2024-12-31:

| Metric | Value |
|---|---|
| Price | $184.71 USD |
| Market Cap | $20.21B |
| P/E (TTM) | -22.55 |
| EPS (TTM) | −$8.19 |
| 52-Week Range | $126.97 – $248.16 |
| Dividend Yield (TTM) | — |

## Dividend

BGNE has no dividend payment history in our records.

## Frequently Asked Questions

### What does BeiGene, Ltd. do?

BeiGene, Ltd. (BGNE) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is BGNE's market cap?

BeiGene, Ltd. (BGNE) has a market capitalization of approximately $20.21 billion, as of December 31, 2024, based on the most recent share price and shares outstanding.

### Does BGNE pay a dividend?

No, BeiGene, Ltd. (BGNE) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is BGNE profitable?

BeiGene, Ltd. (BGNE) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has BGNE ever paid a dividend?

No. Dividend Data's records show no dividend payments from BeiGene, Ltd. (BGNE). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/bgne
- Dividend history & safety: https://www.dividenddata.com/stocks/bgne/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/bgne/earnings
- Financial statements: https://www.dividenddata.com/stocks/bgne/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/bgne/valuation
- Peer comparison: https://www.dividenddata.com/stocks/bgne/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.